KIORA PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $13.81M.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $1.77M.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2020 was $4.50M, a 153.18% increase from fiscal 2019.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2019 was $1.78M, a 82.41% decline from fiscal 2018.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2018 was $10.11M, a 17.38% increase from fiscal 2017.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2017 was $8.61M, a 1188.33% increase from fiscal 2016.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | |
| 2024-03-31 | $13.81M 10-Q · filed 2024-05-10 | |
| 2021-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.76M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $7.99M derived: sum of 4 quarters · filed 2022-07-07 |
| 2021-03-31 | $7.99M 10-Q · filed 2021-05-12 | $7.99M derived: sum of 4 quarters · filed 2022-07-07 |
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $4.50M 10-K/A · filed 2022-07-07 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2020-03-31 | $4.50M 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $1.78M 10-K · filed 2021-03-25 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $10.11M 10-K · filed 2020-03-04 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | |
| 2018-06-30 | $10.15M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $8.61M 10-K · filed 2019-03-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $8.61M derived: sum of 4 quarters · filed 2018-03-02 |
| 2017-06-30 | $6.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $8.61M derived: sum of 4 quarters · filed 2018-03-02 |
| 2017-03-31 | $1.82M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $668.44K 10-K · filed 2018-03-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.10M 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | |
| 2015-03-31 | $4.10M 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |